7274-88-6
Chemical Structure
D-Lysine monohydrochloride
- CAS No.: 7274-88-6
- Formula:C6H15ClN2O2
- Molecular Weight:182.65
IUPAC Name: D-lysine hydrochloride
InChIKey: BVHLGVCQOALMSV-NUBCRITNSA-N
SMILES: N[C@H](CCCCN)C(O)=O.[H]Cl
Biological Activity: D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
D-Lysine monohydrochloride | 99.72% | D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lysine monohydrochloride (Standard) | ≥98% | D-Lysine monohydrochloride (Standard) is the analytical standard of D-Lysine monohydrochloride (HY-Y1804). This product is intended for research and analytical applications. D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-N0470L-Lysine hydrochloride -
Similarity Score 1.00
HY-N0470SL-Lysine-15N2 hydrochloride -
Similarity Score 1.00
HY-N0470S3L-Lysine-13C6,15N2 hydrochloride -
Similarity Score 1.00
HY-N0470S8L-Lysine-13C6 hydrochloride -
Similarity Score 1.00
HY-W027251DL-Lysine Monohydrochloride -
Similarity Score 0.97
HY-N0469S1L-Lysine-13C6 dihydrochloride -
Similarity Score 0.97
HY-N0470S2L-Lysine-13C dihydrochloride -
Similarity Score 0.97
HY-W009762SL-Lysine-13C6,15N2 dihydrochloride -
Similarity Score 0.97
HY-W009762S1L-Lysine6-13C dihydrochloride -
Explore the MedChemAI to find more analogs